QualityStocks
  The QualityStocks Daily Newsletter for Thursday, August 12th 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters

1.

The Stock Psycho (HYPF)

2.

PennyTrader Publisher (MOPN)

3.

Hot Shot Stocks (SMEV)


The QualityStocks Daily

Gold Resource Corporation (GORO)

FeedBlitz reported recently on Gold Resource Corporation (GORO), Wall Street Grand,  OTC Press, Tiny Gems, PennyOmega.com and SmallCap Voice did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Gold Resource Corporation is a mining company focused on production and pursuing development of gold and silver projects. They look for projects that feature low operating costs and produce high returns on capital. The Company has 100 percent interest in five potential high-grade gold and silver properties in Oaxaca, Mexico.  Construction is underway at their flagship property, the El Aguila Project. Trading on the OTCBB, Gold Resource Corporation has their corporate headquarters in Denver, Colorado.

The Company has 100 percent interest in four additional properties located strategically within trucking distance to El Aguila. These are the El Rey high-grade gold property, the Las Margaritas high-grade silver property, and the Solaga high-grade silver property. The Company plans to have their high-grade properties feeding one mill. The Company also has their Alta Gracia Project. They have 100 percent interest in this high-grade silver and gold property. This property is in the exploration phase.

In August 2009, Gold Resource Corporation reported that they were granted the Mexican Federal permit to mine the El Aguila Project's open pit deposit in the southern state of Oaxaca, Mexico. In August, the United States of Mexico's Secretary of the Environment and Natural Resources (SEMARNAT) granted Gold Resource Corporation's 100 percent owned Mexican subsidiary, Golden Trump Resources, S.A. de C.V., federal permission to mine at their El Aguila open pit deposit.

This past April, Gold Resource Corporation announced shipment of the first concentrates for sale from their El Aguila Project. The Company made and sold their first shipment of concentrates under contract to Consorcio Minero de Mexico Cormin Mex, S.A. de C.V. (a Trafigura Group Company). This company took delivery at a Mexican port for ultimate shipment to a smelter. Trafigura is the second largest buyer of concentrates in the world.

On July 1, 2010, Gold Resource Corporation announced Commercial Production as of July 1, 2010 from their 100 percent owned El Aguila high-grade gold and silver project. The Company also announced effective July 1, 2010, the promotion of Mr. Jason Reid to Gold Resource Corporation's President.

The Company estimates the El Aguila Project's mine life at a minimum of 9 years. This is mainly due to their Arista deposit discovered subsequent to their 2007 production decision. Gold Resource Corporation's management is confident that over time the Project's mine life could double or more by expansion of their known deposits alone.

Gold Resource Corporation (GORO) closed Thursday’s trading session at $14.09, up 0.86%, on 93,371 volume with 110 trades. The stock’s average daily volume over the past 60 days is 78,792 with a 52-week low/high of $4.13/$14.24.

Emisphere Technologies, Inc. (EMIS)

Penny Omega reported recently on Emisphere Technologies, Inc. (EMIS), Wall Street Resources did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Emisphere is a biopharmaceutical company that focuses on the unique and improved delivery of therapeutic molecules or nutritional supplements using their proprietary Eligen® Technology. The Eligen® Technology can undergo application to the oral route of administration as well as other delivery pathways. These include buccal, rectal, inhalation, intra-vaginal, or transdermal. Emisphere Technologies, Inc. trades on the OTC Bulletin board and they have their headquarters in Cedar Knolls, New Jersey.

The Company's core business strategy is to use their proprietary Eligen® Technology to develop novel oral forms of injectable drugs or poorly absorbed compounds. Eligen® Technology improves the body's ability to absorb select molecules. Their carriers provide a demonstrated safe method of chaperoning molecules without affecting their biological benefit. Many of these molecules currently deliver via injection, such as salmon calcitonin. In certain cases, their benefits are limited. This is due to poor bioavailability, slow onset of action, or variable absorption, such as Vitamin B12.

Emisphere Technologies, Inc.'s pipeline includes product candidates that have reached clinical development. They also include a variety of preclinical research and development programs. They are carrying out these programs both in collaboration with pharmaceutical and biotechnology companies and independently. Marquee products in the Company's pipeline include an improved formulation of oral Vitamin B12, oral calcitonin for osteoarthritis and osteoporosis (in Phase III development with Novartis), and oral GLP-1 and GLP-1 analogs for Type 2 diabetes.

Emisphere Technologies announced in December of 2009, a meta-analysis published in the December 2009 edition of Rheumatology Reports examining independent evidence of the analgesic action of the hormone calcitonin. This publication restates the potential of calcitonin in filling a significant unmet need for alternative treatments for persistent musculoskeletal pain.

Oral salmon calcitonin uses the proprietary absorption enhancing Eligen® Drug Delivery Technology. It is undergoing study in osteoarthritis and osteoporosis by Novartis Pharma AG and Nordic Bioscience. Scientists from Nordic Bioscience were involved in the preparation of the meta-analysis.

On July 23, 2010, Emisphere Technologies, Inc. announced that Novartis Pharma AG and their license partner Nordic Bioscience a/s (the Sponsor) have reported the following in connection with their Phase III Study 2302 in osteoarthritis assessing the safety and efficacy of oral calcitonin in the treatment of osteoarthritis of the knee. This study incorporates Emisphere's unique and proprietary Eligen® Drug Delivery Technology for the improved oral absorption of salmon calcitonin.

An independent Data Monitoring Committee (DMC) conducted a futility analysis of one-year data for all patients enrolled in this two-year study. This included assessments of safety and efficacy parameters. The DMC concluded that although there is no reason to stop Study 2302 because of safety concerns, there is no reason to continue the study for efficacy. The DMC also concluded that the final decision whether to continue Study 2302 rests with the Sponsor.

Emisphere Technologies, Inc. (EMIS) closed trading at $1.34, up 5.10%, on 223,736 volume with 116 trades. The stock’s average daily volume over the past 60 days is 211,145 with a 52-week low/high of $0.4601/$3.75.

Far East Energy Corporation (FEEC)

Stock Guru, The Street, Undiscoveredequities.com, Cool Penny Stocks, and HotOTC.com reported earlier on Far East Energy Corporation (FEEC), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Far East Energy Corporation focuses on exploring some of the largest coalbed methane (CBM) projects in China. They do this through their agreements with ConocoPhillips and China United Coalbed Methane Company, Ltd. (CUCBM). Coalbed methane, a form of natural gas, is a clean-burning fuel that China plans to use to supply part of their enormous energy needs. Headquartered in Houston, Texas, Far East Energy trades on the OTCBB, and they have additional offices in Beijing, Kunming, and Taiyuan City, China.

The Company's corporate mission is to become a recognized leader in coalbed methane-gas technologies. They are also working towards being a leader in CBM gas property acquisition, exploration, development, production, and innovative products applications. They are concentrating on coalbed methane because of its emergence as a lower cost, lower risk, higher return resource.
 
Far East Energy Corporation began operations on December 31, 2001. In October 2003, they began drilling their first gas well on the Enhong-Laochang coalbed methane (CBM) blocks in the Yunnan Province of southern China. The Yunnan Provincial Coal Geology Bureau (YNCGB) estimates the 264,863 acres covered by the Far East Energy Production Sharing Contract (PSC) contain 5.3 trillion cubic feet (Tcf) of total gas-in-place. The Far East Energy Enhong-Laochang PSC means Far East Energy has a 60 percent working interest, with the other 40 percent owned by China United Coalbed Methane Company, Ltd.

On July 17, 2003, they signed two Farmout Agreements with a ConocoPhillips subsidiary, Phillips China Inc. on the Qinnan and Shouyang CBM blocks in Shanxi Province, P.R.C. and signed an Assignment Agreement on the two blocks. These agreements formalized their acquisition of an undivided forty percent working interest from Phillips' seventy percent interest, with CUCBM retaining the remaining thirty percent. The Shouyang PSC is near Taiyuan City and the Qinnan PSC is near Jincheng and Qinshui.

In October 2009, Far East Energy Corporation announced that a Letter of Intent was signed for the sale of gas produced from their Shouyang Project. The Chinese partner of Far East, China United Coalbed Methane Co. Ltd. (CUCBM) and Shanxi International Energy Co. Ltd. signed this agreement on October 16, 2009. Under the terms of the Production Sharing Contract covering the Shouyang Block, gas produced by Far East and their partner, CUCBM, is sold by CUCBM on behalf of Far East. Shanxi International Energy Co. Ltd. will transport gas produced from the Far East Shouyang block through a pipeline that it will build directly to the area of Far East's current Shouyang gas production. It will then sell this gas to downstream users.

On December 22, 2009, Far East Energy Corporation announced that their wholly owned subsidiary Far East Energy (Bermuda), Ltd. (FEEB), and Arrow Energy International Pte Ltd (AEI), would continue until further notice their Farmout Agreement. With this agreement, subject to the satisfaction of certain conditions, Arrow would farm-in to a 75.25 percent operating interest in FEEB's interest in the Qinnan Coalbed Methane Production Sharing Contract, in Shanxi Province, China.

On June 15, 2010, Far East Energy Corporation announced that they negotiated a Gas Sales Agreement (GSA) with their partner, China United Coal Bed Methane Corporation (CUCBM) and Shanxi Provincial Guoxin Energy Development Group Co., Ltd. (SPG). This is to sell all production of coalbed methane (CBM) from the contract area covered by the Shouyang Production Sharing Contract (the Shouyang Block). The price received by Far East for their gas will be 1.55 Rmb per cubic meter. This includes enacted and recently announced Chinese government subsidies, which equates to approximately $6.55 per Mcf at current exchange rates.

Far East Energy Corporation (FEEC) closed today's session at $0.4250, up 18.06%, on 1,250,376 volume with 149 trades. The stock’s average daily volume over the past 60 days is 337,391 with a 52-week low/high of $0.29/$0.715.

WaferGen Biosystems, Inc. (WGBS)

FeedBlitz reported recently on WaferGen Biosystems, Inc. (WGBS), SmallCap Voice did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

WaferGen Biosystems, Inc. is a leader in the development, manufacture, and sale of state-of-the-art systems for genetic analysis. They have launched their innovative fee-based service for gene-expression profiling. Trading on the OTCBB, the Company is also actively developing their SmartChip™ product for the gene expression and genotyping markets. They designed their SmartChip Real-Time PCR System as the first whole genome, high-throughput gene expression real-time PCR platform. The Company has their headquarters in Fremont, California.   

WaferGen Biosystems currently markets their SmartSlide™ family of products to companies and organizations involved in stem cell and cell biology research. SmartSlide represents the first fluidics integrated micro-incubators enabling cell biology and stem cell research. The SmartSlide™ Micro-Incubation System works seamlessly with inverted microscopes.  This technology is enabling cell biology and stem cell researchers to conduct complex time lapse imaging studies to characterize, differentiate, and proliferate cells. This technology is also enabling them to grow stem, primary, and other difficult to cultivate cells in consistently optimal physiological conditions.

WaferGen Biosystems, Inc. also has their proprietary SmartChip™ Nano-dispenser. The Nano-dispenser is for loading samples and enzymes onto content-ready SmartChips. These are for use with WaferGen's SmartChip™ Real-Time PCR System.

WaferGen Biosystems, Inc. has their innovative service for gene-expression profiling of thousands of genes using the SmartChip™ Real-Time PCR System. Through taking advantage of the SmartChip Real-Time PCR system, WaferGen offers universities, pharmaceutical, and diagnostic companies a service that utilizes pathway-specific gene panels to discover and validate new biomarkers. WaferGen believes the SmartChip Real-Time PCR System will be the first platform to combine the high-throughput capability and cost efficiencies of existing microarrays, with the sensitivity and accuracy of real-time PCR.

On June 10, 2010, WaferGen Biosystems, Inc. announced the availability of two gene expression profiling panels for the SmartChip Real-Time PCR System.  These will enable microRNA and cancer pathway profiling capability.

These panels enable discovery and validation of biomarkers in a high-throughput, highly cost-effective manner. This is by querying up to a thousand genes in a single sample. Recently available only with the SmartChip Gene Expression Profiling Services, provided by WaferGen scientists at the Company's headquarters, the two panels are now available for use by customers on the commercial SmartChip System.

On August 5, 2010, WaferGen Biosystems, Inc. announced that they launched the WaferGen SmartChip Real-Time PCR System. This is the next-generation Real-Time PCR system for discovery and validation of biomarkers, or gene expression patterns, on a single platform.  The design of the SmartChip System is to provide accurate, highly sensitive and high-throughput gene expression profiling capabilities to researchers, clinicians and pharmaceutical companies. 

Today, WaferGen Biosystems, Inc. (WGBS) closed trading at $1.48, up 8.82%, on 358,865 volume with 139 trades. The stock’s average daily volume over the past 60 days is 64,325 with a 52-week low/high of $0.92/$3.15.

Meru Networks, Inc. (MERU)

Today we are highlighting Meru Networks, Inc. (MERU), here at the QualityStocks Daily Newsletter.

Founded in 2002, Meru Networks, Inc. develops and markets a virtualized wireless LAN solution. This solution cost-effectively optimizes the enterprise network to deliver the performance, reliability, predictability, and operational simplicity of a wired network, with the advantages of mobility. Meru Networks, Inc. trades on the NASDAQ Global Market. They have their headquarters in Sunnyvale, California, and have operations in the Americas, Europe, the Middle East and Asia Pacific.

The Company's solutions have undergone adoption in major industry vertical markets. These include education, healthcare, hospitality, manufacturing, and retail. Their solution represents an innovative approach to wireless networking that uses virtualization technology to create an intelligent and self-monitoring wireless network. It also enables enterprises to migrate their business-critical applications from wired networks to wireless networks, and become all-wireless enterprises.

Meru Networks, Inc. announced in April that St. Joseph Health System deployed Meru Networks wireless LAN (WLAN) solutions for implementing a Healthcare Information System (HCIS). This includes Meditech bedside patient registration, medication administration carts (BMV), voice applications for nurse call systems, and asset tracking throughout their network of hospitals and healthcare clinics.

In addition, to ensure best-in-class wireless accessibility, Meru's Service Assurance Manager™ (SAM) provides proactive monitoring of the network around-the-clock, every day. This is to validate end-to-end service levels and identify potential problems in the network before such problems occur.

On June 21, 2010, Meru Networks, Inc. and managed solution provider Aircell, the world's leading provider of inflight connectivity, announced commercial deployment of Meru's virtualized wireless solution on aircrafts equipped with Aircell's Gogo® Inflight Internet Service. This represents a major milestone in their strategic partnership. Passengers will now be able to experience connectivity 35,000 feet in the air that is as dependable as a wired internet service on the ground.

On July 28, 2010, Meru Networks, Inc., announced their financial results for the quarter ended June 30, 2010. Total revenues for the second quarter of fiscal year 2010 were $20.9 million, up 22 percent from $17.1 million in the second quarter of fiscal year 2009. Products and Services revenues were $18.0 million, up 47 percent year-over-year.

Net income (GAAP) was $0.9 million for the second quarter of 2010, or $0.05 per fully diluted share. This is in comparison to a net loss of $2.3 million, or net loss per share of $6.20, for the same period of fiscal year 2009. More than 92 percent of Meru's access point units shipped were 802.11n, more than twice that of the industry average of 38 percent.

Meru Networks, Inc. (MERU) closed today at $12.15, up 8.48%, on 163,974 volume.

NanoViricides, Inc. (NNVC)

FeedBlitz reported last week on NanoViricides, Inc. (NNVC), Stockwire, Penny Omega, Stock Rich, SmallCap Voice, OTC Picks, HotOTC.com, Bull Rally, Cool Penny Stocks, Standout Stocks, StockEgg.com, Penny Invest, Market Wrap Daily did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company designed their novel nanoviricide™ class of drug candidates to specifically attack enveloped virus particles and to dismantle them. Trading on the OTCBB, the Company has their headquarters in West Haven, Connecticut.

NanoViricides Inc. is developing drugs against a number of viral diseases. These include H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. The Company bases their products on TheraCour technology, in development since 1993.

A bactericide specifically recognizes a bacterial cell. It then attaches to it, goes inside, and affects the cell wall synthesis. This destroys the bacterial cell. TheraCour technology enables the same destructive effect against a targeted virus. NanoViricides Inc. has full license to TheraCour technologies for developing nanotechnology-based targeted anti-viral therapeutics.

The Company's anti-viral drugs in early development include FluCide-I™ a targeted nanoviricide against human influenza. Their development goals with HepaCide-I™ are to produce a targeted nanoviricide that attacks, neutralizes, and disables the Hepatitis C virus. For their AviFluCide-I™, NanoViricides Inc. is working to develop a drug against bird (avian) influenza.

NanoViricides' FluCide-HP-I™ is a targeted nanoviricide directed against the Highly Pathogenic (most dangerous) form of various influenzas. The Company's development goals for their HIVCide-I™ is to produce a targeted nanoviricide directed against the HIV viruses. In addition, their RabiCide-I™ is a targeted nanoviricide directed against the rabies virus.

NanoViricides, Inc. is developing FluCide™. This is their flagship anti-influenza drug candidate, to work against all influenza types and subtypes. FluCide has shown to be effective against both common influenza subtype H1N1, as well as two different variants of bird flu subtype H5N1. They are developing a single anti-influenza drug that is expected to be highly effective against all influenzas including the aforementioned, and other pandemic capable highly pathogenic influenza viruses, as well as seasonal influenzas. Their research over the past year enabled them to combine their separate drug programs for highly pathogenic influenzas, bird flu, and seasonal flu into one drug, FluCide™, to treat all influenza variants. The Company has previously announced excellent results in animal studies and cell culture studies against widely different influenza subtypes and strains.

In June, NanoViricides, Inc. reported that their anti-Dengue drug candidates demonstrated significant protection in the initial animal survival studies of Dengue virus infection. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley (UC Berkeley).

Treatment with one of the anti-Dengue nanoviricides® led to survival of 50 percent of the animals for the duration of study in the ADE model. Animals treated with several anti-Dengue nanoviricides survived longer than the control animals treated with vehicle alone. This ADE model of infection is uniformly fatal in 100 percent of the infected animals within five days after infection.

NanoViricides, Inc. (NNVC) closed Thursday’s trading session at $1.21, up 17.48%, on 723,149 volume with 483 trades. The stock’s average daily volume over the past 60 days is 509,348 with a 52-week low/high of $0.41/$2.64.

Sparta Commercial Services Inc. (SRCO)

Ceocast News, Stock Hot Tips, Xplosive Stocks, Stock Stars, Bestotc.com, PennyOmega.com, CRWE Wall Street, DrStockPick.com, Level Stock, and Momentum Traders reported earlier on Sparta Commercial Services Inc. (SRCO), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

Sparta Commercial Services is a nationwide financial services company dedicated to municipal and governmental leasing. Founded in 2001, the Company offers financing and leasing products to consumers and retail powersports dealers. They also offer a variety of commercial products for governmental agencies that require motorcycles and other equipment for law enforcement activities. Trading on the OTCBB, Sparta Commercial Services Inc. has their corporate headquarters in New York, New York.

The Company's management team has experience in financial services, a strong background in powersports financing programs, and a personal devotion to motorcycling. Sparta Commercial Services Inc. serves the financial services needs and interests of powersports dealers and consumers throughout the United States.

Sparta developed a financial services program that offers a broad spectrum of the Company's branded financing programs and other industry related products. These include traditional retail installment contracts (The SPARTA Sport Loan), two leasing products (The SPARTA Flex Lease and The SPARTA Purchase Plus Lease), and the SPARTA Extended Service Contract and Gap Protection Programs. The Company's credit criteria are among the most liberal in the industry. They also have a strong commitment to dealer support.

Their spectrum of financing programs covers all major brands of motorcycles, almost all semi customs, most ATVs, and select scooters. The Company addresses the needs of powersports enthusiasts looking for the best financing source for their next new or used motorcycle, ATV, or select scooter. They also address the needs of dealers who want a one-stop source for liberal credit criteria, a selection of financing products, and the aforementioned dealer support.

Sparta Commercial Services, Inc. offers their Municipal Lease Program. The Sparta program allows governmental agencies to lease, rather than purchase equipment, and therefore extend the payments over a number of years. The program provides a more cost-effective opportunity for municipalities to get the necessary equipment they require. The Sparta Municipal Lease Program can accommodate nearly every type of asset class. In addition to police motorcycles, this includes surveillance equipment, fire and emergency equipment, police cruisers, tactical and utility vehicles, and virtually any type of equipment considered essential by local or state agencies.

On August 6, 2010, Sparta Commercial Services, Inc. announced that Richlands, North Carolina has become the most recent local government to contract with Sparta's nationwide Municipal Lease Program as it adds to its fleet of police cruisers. Richlands is now the seventh jurisdiction in the state of North Carolina alone to take advantage of the Sparta program.

On August 9, 2010, Sparta Commercial Services, Inc. announced the public launch of their new subsidiary, Specialty Reports, Inc. (SRI), DBA Cyclechex. SRI intends to offer online access to detailed product ownership and usage reports for various classes of previously owned assets. SRI's first commercial product release is Cyclechex.

Cyclechex is the first and only online service that will provide detailed motorcycle history reports to consumers, retail dealers, lenders, and insurers. It enables any interested party to have critical information about any motorcycle prior to a purchase, the granting of a loan, or the issuance of insurance coverage.

Sparta Commercial Services Inc. (SRCO) closed Thursday’s trading session at $0.03, for no change, on 135,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 319,470 with a 52-week low/high of $0.01/$0.085.

Timberline Resources Corporation (TLR)

FeedBlitz reported last week on Timberline Resources Corporation (TLR), SmallCap Voice, Stockpalooza, HotOTC.com, Stock Rich, and Cool Penny Stocks did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Timberline Resources Corporation is a diversified gold company. They have three complementary business units. They have a mine in development with anticipated gold production, an active exploration division, and two contract core drilling subsidiaries. Timberline has contract core drilling subsidiaries in the western United States and Mexico and an exploration division focused on district-scale gold projects with the potential for near-term, low-cost development. Trading on the NYSE Amex, Timberline Resources Corporation has their corporate headquarters in Coeur d'Alene, Idaho.

The Company focuses on the evaluation and the acquisition of advanced-stage exploration opportunities, with the potential for near-term development and production. They formed a 50/50 joint venture with Highland Mining, LLC at their royalty-free Butte Highlands Gold Project. It commenced development in the summer of 2009 and has gold production targeted in the near term. Highland Mining, LLC is an affiliate of Small Mine Development.

Timberline Resources Corporation and Staccato Gold Resources Ltd. announced this past March that they entered into a definitive agreement. Timberline acquired, through a court-approved plan of arrangement, all of the issued and outstanding common shares of Staccato by means of a share exchange.

Timberline Resources Corporation acquired Staccato's South Eureka property, which includes a drill-tested exploration portfolio and the advanced-stage Lookout Mountain project, located along Nevada's Battle Mountain - Eureka trend, and approximately $5 million in cash. The South Eureka property consists of several projects included within one of the largest exploration land packages in the Battle Mountain / Eureka Trend - approximately 15,000 acres.

On Aug. 10, 2010, Timberline Resources Corporation announced consolidated financial results for their third fiscal quarter ended June 30, 2010. For the third fiscal quarter of 2010, Timberline reported a consolidated net loss of $0.81 million compared to consolidated net income of 0.24 million in the same fiscal quarter of 2009. The net loss for the third fiscal quarter of 2010 includes expenses of $0.21 million related to the acquisition of Staccato Gold Resources during the quarter. The net income for the third fiscal quarter of 2009 included a one-time recovery of previously expensed professional fees of $0.53 million.

Timberline Resources Corporation (TLR) closed Thursday’s trading session at $0.92, up 5.75%, on 86,601 volume with 123 trades. The stock’s average daily volume over the past 60 days is 238,491 with a 52-week low/high of $0.43/$1.6794.

The QualityStocks Company Corner

Simulated Environment Concepts, Inc. (SMEV)

The QualityStocks Daily Newsletter would like to spotlight Simulated Environment Concepts, Inc. (SMEV). Today, Simulated Environment Concepts, Inc. closed trading at $0.0240, up 140.00%, on 163,111 volume with 13 trades. The stock’s average daily volume over the past 60 days is 174,789 with a 52-week low/high of $0.001/$0.07.

Simulated Environment Concepts, Inc. (SMEV) is focused on manufacturing and distributing their patented SpaCapsule® as well as continued innovation in the areas of anti-aging, cosmetics, relaxation, cellulite reduction, and weight loss. Finding use in numerous environments such as relaxation centers, golf clubs, ski lounges, gyms, and health clubs, the SpaCapsule® provides next generation de-stressing and relaxation.

The company’s founders, Dr. Ella Frenkel and Dr. Ilya Spivak, initially capitalized Simulated Environment Concepts Inc. with several million dollars of their own money. With this initial investment, the company worked on, and succeeded in developing, the sleek and stylish looking pressurized dry water massage relaxation station.

SpaCapsule® is a full body massage, aromatherapy, audio and video entertainment system. The capsules are fused with advanced modern technology and healing methods of aromatherapy and audiovisual relaxation techniques, incorporating proprietary water-jet and pressure-jet technology that requires no on-site plumbing. Weighing approximately 500 lbs, the capsule only requires standard electric service.

Simulated Environment Concepts, Inc. (SMEV) anticipates progressive and consistent growth over the next six years. With individuals spending billions of dollars on de-stressing, weight loss, anti aging, cosmetics, massage and physical rehabilitations, the company is in a position to experience explosive growth from current levels. Disclaimer

Simulated Environment Concepts, Inc. Blog

Simulated Environment Concepts, Inc. News:

Simulated Environment Concepts Attains Pink Sheets Current Information Status

Simulated Environment Concepts Projects European Sales Increase Due To French Distributor's Fast Pace

Simulated Environment Concepts Continues Global Expansion With Another Multi-Million Dollar International Production Deal by Way of United Arab Emirates' Distributor

eDOORWAYS Corporation (EDWY)

The QualityStocks Daily Newsletter would like to spotlight eDOORWAYS Corporation (EDWY) Today eDoorways Corporation closed trading at $0.0038, up 22.58%, on 12,226,200 volume with 53 trades. The stock’s average daily volume over the past 60 days is 2,877,889 with a 52-week low/high of $0.0011/$0.16.

eDOORWAYS Corp. (EDWY) is committed to solving lifestyle problems for consumers while driving traffic to suppliers and service providers who offer innovative merchandise and solutions. The company has the potential to completely change the future landscape of business by offering a unique and comprehensive service that saves consumers valuable time and money. By uniting a consumer with the larger global consumer community, retailers, and manufacturers in an effective new way, eDOORWAYS promotes “dynamic” commerce, as opposed to the static model currently in existence.

The Company plans to capitalize on several emerging new trends. These newly created opportunities include: the large success of Web 2.0 Internet community service offerings such as MySpace, the movement towards niche marketing and targeted advertising, the introduction of new technologies that enable instantaneous, online presentation of information, and the rising consumer preference for using the Internet to gain information before making purchasing decisions.

eDOORWAYS plans to introduce local services using a city-by-city strategy that will minimize capital requirements, reduce staffing requirements, and optimize generated revenues. Ten major cities are targeted for launch in the first year. Advertising, PR campaigns and viral word-of-mouth will be used to give a public presentation to experts as well as educate the market.

The key benefits offered to consumers include a higher level of engagement with vendors, trusted information from other consumers, and superior customer service. Revenues will be generated through advertising placement fees, premium services, preferential placement fees, and a percentage of sales transactions. eDOORWAYS' progressive vision and professional management team makes it an attractive investment opportunity. Disclaimer

eDOORWAYS Corporation Blog

eDOORWAYS Corporation News:

In A New Audio Interview at SmallCapVoice.com, Dr. Ramiro Jordan Discusses the New Technology from eDoorways Corporation

eDoorways Files Form 15, Focuses on Securing Additional Revenue Opportunities

eDoorways - CorkSport, Sign First PowerKey Channel Deal

NetSol Technologies, Inc. (NTWK)

The QualityStocks Daily Newsletter would like to spotlight NetSol Technologies, Inc. (NTWK). Today, NetSol Technologies, Inc. closed trading at $0.81, up 3.51%, on 154,255 volume with 258 trades. The stock’s average daily volume over the past 60 days is 147,323 with a 52-week low/high of $0.70/$1.31.

NetSol Technologies, Inc. (NTWK) a worldwide provider of global business services and enterprise application solutions, leverages its BestShoring(TM) practices and highly experienced resources to deliver high-quality, cost-effective solutions. The ir suite of products and services include credit and finance portfolio management systems, hospital/healthcare information management systems (HIMS), SAP consulting and services, custom development, systems integration, and technical services.

NetSol’s commitment to quality is demonstrated by its achievement of the ISO 9001, ISO 27001, and SEI (Software Engineering Institute) CMMI (Capability Maturity Model) Maturity Level 5 assessments, a distinction shared by less than 100 companies worldwide. These distinctions are a result of adhering to rigorous quality standards, resulting in the delivery of solutions that are secure, reliable, properly planned, and meticulously executed.

Serving the global financial, healthcare, insurance, energy, and technology markets, NetSol has operations, offices, and joint ventures in Adelaide, Bangkok, Beijing, Lahore, London, Riyadh, San Francisco, and San Pedro Sula. NetSol Technologies' clients include Fortune 500 manufacturers, global automakers, financial institutions, utilities, technology providers, and government agencies.

NetSol Technologies, Inc. (NTWK), is well positioned with its core product offerings as it continues to expand into new international market opportunities. Looking forward, the company is very optimistic of its short-term and long-term outlook as it sees strong growth in Asia Pacific as well as the South East Asian markets, while also envisioning unlimited potential for its niche solutions and services in the Americas. Disclaimer

NetSol Technologies, Inc. Blog

NetSol Technologies, Inc. News:

CRWE Wallstreet Announces Stock Watch on SSHO, ENOC, ASTM, NTWK

NetSol North America Sales Rebound After Stream of New Orders From Existing Clients

NetSol Announces the Successful Implementation of NFS Solution by Minsheng Financial Leasing Co., Ltd.

Micro Identification Technologies Inc. (MMTC)

The QualityStocks Daily Newsletter would like to spotlight Micro Identification Technologies Inc. (MMTC) Today Micro Identification Technologies Inc. closed trading at $0.0270, up 22.73%, on 308,070 volume with 15 trades. The stock’s average daily volume over the past 60 days is 264,923 with a 52-week low/high of $0.02/$0.14.

Micro Identification Technologies Inc. (MMTC) is focused on becoming a global leader in developing, supporting and marketing rapid systems and processes that detect and identify microbial organisms. For several years the company has been working on the development of a breakthrough, laser-based microbial identification technology. This technology has been designed to be extremely fast and easy to use while not relying on conventional chemical or biological processing, fluorescent tags, gas chromatography or DNA analysis.

The system works by measuring scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. By measuring scattered light at specific angles, MIT’s system detects and differentiates objects the size of bacteria, protozoa, yeasts and molds.

The company’s technology offers significant advantages over today’s methods of microbial detection, including lower cost, rapid results, easier use and the ability to test for multiple bacteria in one process. The system is statistically based and includes a unique MIT Microbe Library of pre-measured light scattering identifiers - or fingerprints - derived from the measurements of tens of thousands of individual microbes for each species and subspecies to be detected.

MIT’s technology has the potential to revolutionize the $5 billion rapid microbial test market by annually saving thousands of lives and tens of millions of dollars. Since 1998, the industry has had an annual expansion of 9.2 percent - with growth projections for 30 percent annually. MIT is well positioned with its cutting-edge microbial technology as demand continues to soar as a result of major health, safety and homeland security issues. Disclaimer

Micro Identification Technologies Inc. Blog

Micro Identification Technologies Inc. News:

MIT Initiates Expansion Plans Enabled by Recently Completed Manufacturing and Financing Agreements

MIT Contracts OSI Optoelectronics to Manufacture the MIT 1000 Rapid Microbial Identification System

U.S. Equity News Features Micro Identification Technologies in the Fight Against Bacteria

The Greening Of Uranium

In 1932, Albert Einstein, considered by many to be the most influential scientist of the 20th century, made a startling prediction. Einstein, who years before had unlocked the possibility of virtually unlimited energy with his equation E = MC2, said confidently “There is not the slightest indication that nuclear energy will ever be obtainable. It would mean that the atom would have to be shattered at will.” Just 13 years later the world was blasted into the nuclear age with the detonation of the first nuclear explosion in the New Mexican desert, followed shortly by the obliteration of Hiroshima and Nagasaki Japan. The resulting deaths of between 150,000 and 246,000 people were a frightening confirmation that the power of the atom was indeed accessible.

Approximately 6 years after the creation of the bomb, nuclear generated electricity became a reality at a small test station in eastern Idaho. It only amounted to about 100 kilowatts, and was not even part of the grid, but it opened the door to a brand new source of controlled energy. It also spurred a new market for uranium, the dense gray metal originally used only for coloring glass and ceramics. Ironically, the United States was at first sluggish to push the new industry that it had invented. But, as operating nuclear power plants began to appear in the U.S.S.R. and Europe, America soon jumped on board, and in a big way.

It wasn’t long before the U.S. was producing more nuclear power than anyone, though it still only represents about 20% of the county’s total electrical production (France produces about 78% of its electricity from nuclear reactors). Uranium was riding a huge and global nuclear energy wave, a wave that crashed in the 1980s as people began to focus on concerns about safety and environmental issues relating to nuclear power plants. The nuclear accidents at Three Mile Island in Pennsylvania, and later at Chernobyl, effectively shut down the growth of nuclear power in the U.S. and much of the world. The reduction in nuclear weapons resulting from the end of the Cold War seemed to be a final nail in uranium’s coffin.

By the turn of the millennium, the collapsing price of uranium had made exploration and development a distant memory. But then something happened, a change in the perception of energy generation so fundamental and widespread, that it was like a hand reaching down and pulling nuclear energy from the grave. It can be argued that the savior of nuclear power can be summed up in two words: Global Warming.

As concerns about the potential long term effects of fossil fuels began to grow, governments around the world came under increasing pressure to find alternatives. Solar and wind and other energy sources have long been promoted, but only nuclear energy has already proven itself on a large scale as a consistent source of reliable power. All this as China and other nations began to flirt with free market economics, growing their productivity and associated demand for energy. The result was inevitable. Uranium, once on the environmental movement’s hit list, was suddenly taking on a shade of green.

Today, dozens of new nuclear power plants are under construction in places like China, India, and Russia, and there is an estimated uranium supply shortfall of 80 million pounds per year. The U.S., once a major uranium producer, long since overshadowed by places like Canada and Australia, is again in the uranium business. In North America, publicly traded uranium exploration and development companies include the following.

• Cameco (NYSE:CCJ) – Based in Saskatchewan, and one of the largest
• Golden Patriot Corp. (GPTC.OB) – Uniondale, NY, based uranium development company, with projects in Arizona and Nevada
• Uranium International Corp. (URNI.OB) – London based uranium mining company with operational offices in New Mexico, and projects in Sweden
• Black Hawk Exploration (BHWX.OB) – California based exploration company with properties in Canada and the U.S., though currently focused on gold and lithium

One of the newest, and most remarkable such companies, is Texas-based Uranium Energy Corp (NYSE-AMEX: UEC). The company, headed by a management team made up of entrepreneurs and industry experts from some of the most successful companies around, controls one of the largest databases of historic uranium exploration and development in the country. The one-of-a-kind uranium site database has allowed them to quickly identify and target for acquisition properties that have the best chances for immediate production, properties that could increase dramatically in value as uranium demand continues to grow. UEC is well financed, unlike many uranium exploration and development companies, and appears to have one of the best chances to take off as uranium continues its transition from gray to green.

NetSol Technologies (NTWK) Takes Security Seriously

One of the most important set of products and services offered by global enterprise software and support provider NetSol Technologies Inc. is their full range of information security solutions. These days, protecting the confidentiality, veracity, and accessibility of proprietary information is becoming one of the biggest problems faced by corporate America. NetSol covers the bases, first by comprehensively investigating and understanding a client’s technological and business security requirements and vulnerabilities, and then by working closely with the client, applying the most advanced technologies available, addressing both short term and long term needs.

Specifically, the company offers the following information security consulting services:
• Enterprise Security Analysis
• Penetration Testing & Vulnerability Assessment
• Information Security Audit
• Secure Network Design & Deployment
• Business Continuity/Disaster Recovery Planning
• ISO 20000 and 27001 Lifecycle Consulting

The testing and evaluation is, in a word, merciless. For example, NetSol’s Penetration Testing & Vulnerability Assessment systematically evaluates the security of the client’s information network by actually simulating an attack by a malicious user. Analysis is carried out from the position of an attacker, trying every trick possible to detect vulnerabilities. When even the slightest weaknesses are found, they are presented, along with the options available to plug the leak.

NetSol’s Network Design & Deployment process offers product-independent network designs, as well as design reviews, with an emphasis on all potential vulnerabilities and network management shortfalls. NetSol works directly with the client’s IT management to identify the current and future networking requirements and security measures, and validates the design in a real-world environment.

NetSol’s Business Continuity Planning/Disaster Recovery services are designed to ensure the most effective, robust, and sustainable plans available, carefully aligned with the infrastructure and applications that support them. They use international best practices and standards, including ISO 27001/BS7799 and ISO 25999.

Finally, regarding specific security products, NetSol is known for applying only the best:
• IBM Tivoli Security Solutions
• IBM Tivoli Security Information & Event Management (TSIEM)
• IBM Tivoli Identity Manager (TIM)
• IBM Tivoli Access Manager (TAM)
• IBM Tivoli Enterprise Single Sign-On
• IBM Enterprise Protection Products
• IBM Proventia Network Intrusion Prevention System
• IBM Proventia Multi-Function Security
• IBM Proventia Enterprise Scanner & Internet Scanner Software
• IBM Proventia Network Mail Security System
• IBM Proventia Management SiteProtector System
• Kaspersky Open Space Security
• Kaspersky Work Space Security
• Kaspersky Business Space Security
• Kaspersky Enterprise Space Security
• Kaspersky Total Space Security

CAMAC Energy Inc. (CAK) is “One to Watch”

CAMAC Energy Inc. is a dynamic, independent energy company that targets high return, early cash flow global energy projects. Maintaining a balanced portfolio which includes upstream operations and downstream opportunities in Asia and West Africa, the company is committed to building success through strategic vision, unparalleled experience, and responsible corporate governance.

The company’s principal assets include interests in the Oyo Oilfield, an offshore oil asset in deepwater Nigeria that started production in December 2009; a 100% interest in the Zijinshan CBM gas asset located in the Shanxi Province, China; and the Enhanced Oil Recovery and Production (EORP) business in Northern China. Headquartered in Hartsdale, New York, CAMAC Energy has additional offices in Houston, Texas; Beijing, China; and Lagos, Nigeria.

CAMAC Energy strives to maximize shareholder value by actively identifying and managing high-return global energy projects. The company reduces exposure and risks through diversification and a balanced portfolio of assets that offer both short-term cash flow and long-term growth potential. As part of their business strategy, CAMAC Energy actively manages its investments and on-going operations by forming strategic partnerships and alliances.

Earlier this week the company announced its financial results for the second quarter ended June 30, 2010. In the news release, CAMAC Energy noted a “transformation in the cash flow story” as second quarter cash flow from operations increased to a positive $15.6 million from a negative $2.6 million for the same period in 2009. Also notable, the company reported no short-term or long-term debt, other than $6.8 million related to the Oyo Oilfield acquisition which has since then been paid in full.

In other recent news, CAMAC Energy signed a memorandum of understanding (“MOU”) with CAMAC Energy Holdings Limited, CAMAC International (Nigeria) Limited, and Allied Energy Resources Nigeria Limited to acquire full interest in Oil Mining Leases 120 and 121 located offshore Nigeria. The companies intend to finalize negotiations and related due diligence with a goal of entering into a definitive agreement on or before October 15, 2010.

Commenting on the MOU, CEO Mr. Bill Dozier, stated the following, “We are very excited about the growth opportunities this acquisition could bring to our Company. This builds upon the successful movement by the Company to a cash flow positive position which we announced yesterday in our second quarter results and which is further elaborated in my Letter to Shareholders which was posted on our Company website today (www.camacenergy.com).”

With a strong track record of rapid success and a hard working management team actively pursuing additional growth opportunities, CAMAC Energy is a company investors will want to keep an eye on.

Genta, Inc. (GETAD) Reports Second Quarter 2010 Corporate Highlights and Financial Results

Genta Inc. is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The company announced today financial results for its 2010 second quarter as well as corporate highlights.

For the second quarter of 2010, Genta reported net income of $25.4 million compared with a reported net loss of $43.1 million in the second quarter of 2009. For the six months ended June 30, 2010, the company reported a net loss of $141.2 million versus a net loss of $54.1 in the same period last year. As of June 30, 2010, Genta had cash and cash equivalents totaling $15.6 million, compared with $1.2 million on hand at the end of 2009.

These results include the net impact of the mark-to-market accounting for the liabilities of the conversion features of its notes, warrants and debt warrants that were issued in the company’s financings, including the financing that was closed in March 2010. These liabilities fluctuate according to the price of Genta’s common stock. It was these fluctuations that caused the company to report positive net income for the second quarter of 2010.

In June 2010, Genta received stockholder approval to authorize a reverse stock split of its common stock. Subsequently, a 1-for-100 reverse stock split was approved by the company’s board of directors and became effective on August 2, 2010.

Corporate highlights for the second quarter of 2010 included:
• Survival results from AGENDA Phase 3 trial of Genasense in advanced melanoma on track for expected followup completion in the first quarter of 2011.
• Pooled results from two Phase 3 trials of Genasense confirm significance of secondary endpoints.
• New Ganite clinical trial initiated for treatment of serious infections in cystic fibrosis.
• Tesetaxel dose-ranging studies show potential activity in taxane-resistant breast cancer.

 


Sponsors of the Day

 

The QualityStocks Public Company Sponsor News

Micro Identification Technologies Inc. (MIT) (MMTC) MIT Initiates Expansion Plans Enabled by Recently Completed Manufacturing and Financing Agreements

QualityStocks


 

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336